JPRN-jRCT1080223148已完成Unknown
Special drug use surveillance of Leuplin PRO for Injection Kit 22.5 mg in Premenopausal breast cancer
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 312
研究概览
简要总结
These results suggest that there are no new safety concerns about Leuplin PRO associated with its characteristics (e.g., increased amount administered per dose, different time-course of serum drug concentrations) compared with Leuplin SR. Please refer to Conclusions in "Adverse Events" section for the details.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- •Participants with premenopausal breast cancer will be included.
排除标准
- •Participants who meet any of the following criteria will not be included.
- •Participants with a history of hypersensitivity to any ingredients of Leuplin PRO, synthesized LH-RH, or LH-RH analogues
- •Pregnant or potentially pregnant participants and breastfeeding participants
研究者
相似试验
未知
Unknown
Special drug use surveillance of Leuplin PRO for Injection Kit 22.5 mg for Prostate cancerProstate cancerJPRN-jRCT1080223158TAKEDA PHARMACEUTICAL COMPANY LTD.333
已完成
Unknown
The special drug use surveillance of INAVIR for inhalation suspension set (Safety evaluation in pediatric patients under five years old)Influenza virus infectionJPRN-jRCT1080224937DAIICHI SANKYO CO., LTD.1,156
已完成
不适用
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"Prostate CancerNCT03209492Takeda333
已完成
Unknown
Special drug use surveillance of Vonoprazan for prevention of recurrence of gastric/duodenal ulcer in patients receiving low-dose aspirin: long-term useGastric or duodenal ulcersJPRN-jRCT1080223380Takeda Pharmaceutical Company Limited1,119
已完成
Unknown
Special Drug Use Surveillance of Vonoprazan for Maintenance Therapy of Reflux Esophagitis: Long-term UseJPRN-jRCT1080223147Takeda Pharmaceutical Company Limited1,237